Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| 1 |
Apple
AAPL
|
+$2.98B |
| 2 |
NVIDIA
NVDA
|
+$1.91B |
| 3 |
Broadcom
AVGO
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.51B |
| 5 |
Amazon
AMZN
|
+$1.3B |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$876M |
| 2 |
UnitedHealth
UNH
|
+$780M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$647M |
| 4 |
Marsh & McLennan
MMC
|
+$621M |
| 5 |
PepsiCo
PEP
|
+$445M |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Financials | 12.47% |
| 3 | Consumer Discretionary | 11.86% |
| 4 | Healthcare | 11.61% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Guardant Health
GH
$7.41B
| $1.39K | ﹤0.01% |
33
+22
| +200% | +$925 |
|
|
INGM
1902
Ingram Micro Holding Corporation
INGM
$4.8B
| $1.39K | ﹤0.01% |
+82
| New | +$1.39K |
|
|
FNA
1903
DELISTED
Paragon 28, Inc.
FNA
| $1.37K | ﹤0.01% |
105
-4
| -4% | -$52 |
|
|
KREF
1904
KKR Real Estate Finance Trust
KREF
$646M
| $1.37K | ﹤0.01% |
134
+4
| +3% | +$41 |
|
1905
Brookfield Infrastructure
BIPC
$4.83B
| $1.36K | ﹤0.01% |
+37
| New | +$1.36K |
|
1906
Enovis
ENOV
$1.78B
| $1.35K | ﹤0.01% |
40
| – | – |
|
1907
Scholar Rock
SRRK
$3.04B
| $1.35K | ﹤0.01% |
44
+21
| +91% | +$645 |
|
1908
Capri Holdings
CPRI
$2.54B
| $1.35K | ﹤0.01% |
+90
| New | +$1.35K |
|
1909
Boyd Gaming
BYD
$6.92B
| $1.33K | ﹤0.01% |
21
+3
| +17% | +$190 |
|
1910
American Express Global Business Travel
GBTG
$4.35B
| $1.33K | ﹤0.01% |
192
+130
| +210% | +$900 |
|
1911
CVB Financial
CVBF
$2.78B
| $1.31K | ﹤0.01% |
77
+44
| +133% | +$751 |
|
1912
Green Dot
GDOT
$766M
| $1.3K | ﹤0.01% |
159
-27,595
| -99% | -$225K |
|
1913
Independent Bank Corp
IBCP
$682M
| $1.29K | ﹤0.01% |
45
+1
| +2% | +$29 |
|
1914
Integra LifeSciences
IART
$1.22B
| $1.28K | ﹤0.01% |
64
+36
| +129% | +$722 |
|
1915
Zymeworks
ZYME
$1.15B
| $1.25K | ﹤0.01% |
106
+54
| +104% | +$635 |
|
|
AMPS
1916
DELISTED
Altus Power, Inc.
AMPS
| $1.24K | ﹤0.01% |
+250
| New | +$1.24K |
|
1917
Camden National
CAC
$686M
| $1.23K | ﹤0.01% |
33
+17
| +106% | +$634 |
|
1918
Apogee Therapeutics
APGE
$2.29B
| $1.23K | ﹤0.01% |
35
+23
| +192% | +$805 |
|
1919
XPEL
XPEL
$1.06B
| $1.23K | ﹤0.01% |
44
| – | – |
|
1920
Invesco Mortgage Capital
IVR
$521M
| $1.17K | ﹤0.01% |
148
| – | – |
|
1921
Horizon Bancorp
HBNC
$852M
| $1.15K | ﹤0.01% |
+83
| New | +$1.15K |
|
1922
IDEAYA Biosciences
IDYA
$2.05B
| $1.14K | ﹤0.01% |
73
+40
| +121% | +$623 |
|
1923
Asana
ASAN
$3.29B
| $1.13K | ﹤0.01% |
78
+35
| +81% | +$508 |
|
1924
Denali Therapeutics
DNLI
$2.25B
| $1.13K | ﹤0.01% |
88
+3
| +4% | +$38 |
|
1925
MasTec
MTZ
$13.9B
| $1.12K | ﹤0.01% |
+10
| New | +$1.12K |
|